JP Morgan Upgrades Corteva to Overweight, Lowers Price Target to $19

Benzinga · 4d ago
JP Morgan analyst Jeffrey Zekauskas upgrades Corteva (NYSE:CTVA) from Neutral to Overweight and lowers the price target from $83 to $19.